Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 2/20 | 0.58 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.58 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.58 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | FAAH | O00519 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | CNR1 | P21554 | 1/20 | 0.55 |
| ▸ | CNR2 | P34972 | 1/20 | 0.55 |
| ▸ | DGKA | P23743 | 1/20 | 0.54 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.53 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.53 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.53 |
| ▸ | TERT | O14746 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1034386 | 1.00 | PRKCA (0.58) | PRKCAPRKCEPRKCQPRKCDLMNA | |
| SCHEMBL3656169 | 1.00 | PRKCA (0.58) | PRKCAPRKCEPRKCQPRKCDLMNA | |
| SCHEMBL3660598 | 0.96 | ALDH1A1 (0.62) | PRKCEPRKCQPRKCDLMNAFAAH | |
| SCHEMBL10891626 | 0.94 | PRKCA (0.56) | PRKCAPRKCEPRKCQPRKCDLMNA | |
| SCHEMBL10891637 | 0.94 | PRKCA (0.56) | PRKCAPRKCEPRKCQPRKCDLMNA | |
| SCHEMBL9439767 | 0.92 | LMNA (0.62) | PRKCAPRKCEPRKCQPRKCDLMNA | |
| SCHEMBL17639936 | 0.92 | LMNA (0.62) | PRKCAPRKCEPRKCQPRKCDLMNA | |
| SCHEMBL822918 | 0.92 | LMNA (0.62) | PRKCAPRKCEPRKCQPRKCDLMNA | |
| SCHEMBL9440104 | 0.92 | LMNA (0.62) | PRKCAPRKCEPRKCQPRKCDLMNA | |
| SCHEMBL3661566 | 0.91 | CNR1 (0.68) | LMNAFAAHMAPTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 275 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110283404-B | Halogen-free flame-retardant PVC material and preparation method thereof | 杭州唐邦塑胶有限公司 | 2021-06-22 | — | — | CN | claimed |
| CN-110523914-A | A kind of preparation method of high temperature heat-resistant impact casting sand | HANSHAN RONGSHENG MACHINERY CASTING CO LTD | 2019-12-03 | — | — | CN | claimed |
| CN-110283404-A | A kind of halogen-free flameproof PVC material and preparation method thereof | 郭庆 | 2019-09-27 | — | — | CN | claimed |
| CN-105348568-A | Formula of cellulose modified cement woven bag | ZHANGJIAGANG XIUHUA PLASTIC FACTORY | 2016-02-24 | — | — | CN | claimed |
| US-8425784-B2 | Ozonolysis reactions in liquid CO2 and CO2-expanded solvents | UNIVERSITY OF KANSAS (US) | 2013-04-23 | — | — | US | claimed |
| CN-101437494-A | Modified release solid dosage form of grade 0 | MALLINCKRODT INC (US) | 2009-05-20 | — | — | CN | claimed |
| EP-2020995-A2 | ZERO-ORDER MODIFIED RELEASE SOLID DOSAGE FORMS | Mallinckrodt Inc. (US) | 2009-02-11 | — | — | EP | claimed |
| WO-2007133583-A2 | ZERO-ORDER MODIFIED RELEASE SOLID DOSAGE FORMS | MALLINCKRODT INC. (US) | 2007-11-22 | — | — | WO | claimed |
| US-4618441-A | ANTIDEPOSIT AGENTS | ALUMINUM COMPANY OF AMERICA (US) | 1986-10-21 | — | — | US | claimed |
| US-4585565-A | Metalworking lubricant comprising mineral oil and alkoxyalkyl ester | ALUMINUM COMPANY OF AMERICA (US) | 1986-04-29 | — | — | US | claimed |
| WO-2025080559-A1 | METHODS AND COMPOSITIONS FOR TREATING DRUG OVERDOSE | ENALARE THERAPEUTICS INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| US-20250114370-A1 | METHODS AND COMPOSITIONS FOR TREATING DRUG OVERDOSE | ENALARE THERAPEUTICS INC (US) | 2025-04-10 | — | — | US | disclosed |
| US-20250031718-A1 | NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) COMPOSITIONS, METHODS OF MANUFACTURING THEREOF, AND METHODS OF USE THEREOF | SOVIDA SOLUTIONS LTD (GB) | 2025-01-30 | — | — | US | disclosed |
| US-20250032496-A1 | METHODS OF TREATING RESPIRATORY DEPRESSION MODULATED BY A NON-OPIOID AGENT | ENALARE THERAPEUTICS INC (US) | 2025-01-30 | — | — | US | disclosed |
| US-20250010049-A1 | ORAL DELIVERY OF ACTIVE DRUG SUBSTANCES | Biograil ApS (DK) | 2025-01-09 | — | — | US | disclosed |
| US-4585565-A | Metalworking lubricant comprising mineral oil and alkoxyalkyl ester | ALUMINUM COMPANY OF AMERICA (US) | 1986-04-29 | — | — | US | disclosed |
| US-4555476-A | Heat development process with stabilizer | FUJI PHOTO FILM CO., LTD. (JP) | 1985-11-26 | — | — | US | disclosed |
| US-4364743-A | ESTER AND MIDDLE OIL | ERNER WILLIAM E | 1982-12-21 | — | — | US | disclosed |
| US-3952347-A | Biodegradable barrier film and absorbent pad utilizing same | PERSONAL PRODUCTS COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
| US-3936403-A | Synthetic resin composition | SHOWA DENKO KABUSHIKI KAISHA (JA) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250010049-A1 | ORAL DELIVERY OF ACTIVE DRUG SUBSTANCES | ABCB1, EPCAM, ABCB11 | PRKCA 4845/4885PRKCE 4848/4885PRKCQ 4699/4885 |
| US-20250032496-A1 | METHODS OF TREATING RESPIRATORY DEPRESSION MODULATED BY A NON-OPIOID AGENT | OPRK1, OPRM1, OPRD1 | PRKCA 4102/4885PRKCE 4216/4885PRKCQ 3017/4885 |
| US-20250114370-A1 | METHODS AND COMPOSITIONS FOR TREATING DRUG OVERDOSE | ADRA2A, ADRA2C, OPRM1 | PRKCA 1976/4885PRKCE 1634/4885PRKCQ 1444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.